Serial Magnetic Resonance Spectroscopy Reveals a Direct Metabolic Effect of Cediranib in Glioblastoma
Data up to Jan 2025
Total Citations Per Year
Abstract
References (49)
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
1992 • 4,631 citations
Estimation of metabolite concentrations from localized in vivo proton NMR spectra
1993 • 3,535 citations
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 • 2,176 citations
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
2004 • 1,935 citations
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
2007 • 1,742 citations
Spatial Localization in NMR Spectroscopy in Vivo
1987 • 1,342 citations
Angiogenesis in brain tumours
2007 • 1,314 citations
Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
2006 • 1,305 citations
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
1994 • 1,249 citations
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
2004 • 1,176 citations
NMR chemical shift imaging in three dimensions.
1982 • 1,033 citations
1H NMR chemical shift selective (CHESS) imaging
1985 • 1,016 citations
Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis.
1995 • 699 citations
WET, a T1- and B1-Insensitive Water-Suppression Method for in Vivo Localized 1H NMR Spectroscopy
1994 • 682 citations
Diffusion Magnetic Resonance Imaging: an Early Surrogate Marker of Therapeutic Efficacy in Brain Tumors
2000 • 677 citations
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
2009 • 580 citations
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiationRole of oxygenation, angiopoietin-1, and matrix metalloproteinases
2004 • 549 citations
Phase II Study of Cediranib, an Oral Pan–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
2010 • 502 citations
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
2009 • 494 citations
Role of Vascular Endothelial Growth Factor in Ovarian Cancer
1998 • 396 citations
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study
1996 • 363 citations
Multisection proton MR spectroscopic imaging of the brain.
1993 • 355 citations
Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors
1994 • 301 citations
Edema Control by Cediranib, a Vascular Endothelial Growth Factor Receptor–Targeted Kinase Inhibitor, Prolongs Survival Despite Persistent Brain Tumor Growth in Mice
2009 • 299 citations
Human brain tumors: assessment with in vivo proton MR spectroscopy.
1993 • 287 citations
Human brain tumors: spectral patterns detected with localized H-1 MR spectroscopy.
1992 • 265 citations
Antiangiogenic Therapy of a Recurrent Giant Cell Tumor of the Mandible With Interferon Alfa-2a
1999 • 245 citations
Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra
2006 • 228 citations
In Situ Expression of Angiopoietins in Astrocytomas Identifies Angiopoietin-2 as an Early Marker of Tumor Angiogenesis
1999 • 222 citations
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
1992 • 218 citations
1H MR spectroscopy of brain tumours and masses
2003 • 211 citations
Multivoxel magnetic resonance spectroscopy of brain tumors.
2003 • 201 citations
Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume
2004 • 193 citations
VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer
2009 • 187 citations
In Vivo 3-T MR Spectroscopy in the Distinction of Recurrent Glioma versus Radiation Effects: Initial Experience
2002 • 149 citations
What brings pericytes to tumor vessels?
2003 • 143 citations
Choline Phospholipid Metabolism in Cancer: Consequences for Molecular Pharmaceutical Interventions
2006 • 142 citations
Classification of biopsy-confirmed brain tumors using single-voxel MR spectroscopy.
1999 • 129 citations
Vascular morphology and angiogenesis in glial tumors
1995 • 126 citations
Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor
2000 • 106 citations
Proton Magnetic Resonance Spectroscopy of Pediatric Brain Tumors
1992 • 101 citations
Proton MR spectroscopy of common brain tumors.
1998 • 90 citations
Proton magnetic resonance spectroscopy of late delayed radiation-induced injury of the brain
1999 • 90 citations
Radiation-induced changes in human brain metabolites as studied by 1H nuclear magnetic resonance spectroscopy in vivo
1995 • 87 citations
Successful Antiangiogenic Therapy of Giant Cell Angioblastoma With Interferon Alfa 2b: Report of 2 Cases
2002 • 78 citations
High-resolution 1H-magnetic resonance spectroscopy of pediatric posterior fossa tumors in vitro
1994 • 62 citations
Role of short TE 1H-MR spectroscopy in monitoring of post-operation irradiated patients
1999 • 41 citations
Hydrogen Magnetic Resonance Spectroscopy Follow-up After Radiation Therapy of Human Brain Cancer Unexpected Inverse Correlation Between the Changes in Tumor Choline Level and Post-Gadolinium Magnetic Resonance Imaging Contrast
1995 • 34 citations
Proton magnetic resonance spectroscopy (1H-MRS) for the evaluation of treatment of brain tumours
1995 • 24 citations